InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: ClosetInvestor post# 156146

Thursday, 04/01/2021 10:55:14 PM

Thursday, April 01, 2021 10:55:14 PM

Post# of 232880
There are no FDA accepted cellular biomarkers for Covid19 except viral load and Leronlimab is not an antiviral. So what would they use advanced diagnostics to test for in the realm of a clinical trial?
These were important in the basic research and the incellDX tests performed that function so that CytoDyn felt confident to move from research into the clinical trials. If Leronlimab is approved then testing for these biomarkers might be important in further trials to expand the label. First they need to show it has efficacy then can show it might have further efficacy in other indications centering on the RANTES pathway.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News